Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 58

    Biocon Foundation signs MoU with Karnataka govt on Smart clinics

    Biocon Foundation signs MoU with Karnataka govt on Smart clinics

    supriya kashyap kashyap9 Feb 2017 11:34 AM IST
    Bengaluru : Biocon Foundation, the CSR arm of biotech company Biocon, has signed an MoU with Karnataka Health and Family Welfare Department to...
    Medical devices rules notified on Jan 31: Ananth Kumar

    Medical devices rules notified on Jan 31: Ananth Kumar

    supriya kashyap kashyap9 Feb 2017 11:31 AM IST
    New Delhi : Government has notified a bill related to manufacturing of medical devices, including coronary stents, in the country in order to...
    FDA seizes unlicensed medical devices worth over Rs 1 crore from GT Hospital

    FDA seizes unlicensed medical devices worth over Rs 1 crore from GT Hospital

    supriya kashyap kashyap8 Feb 2017 11:16 AM IST
    Mumbai : The Maharashtra Food and Drug Administration officials have seized unlicensed medical devices worth over Rs 1 crore, FDA commissioner...
    Online Sale of Medicines: Govt Committee Recommendations

    Online Sale of Medicines: Govt Committee Recommendations

    supriya kashyap kashyap8 Feb 2017 10:44 AM IST
    A Sub-Committee had been constituted by the Drugs Consultative Committee (DCC) to examine issues relating to online sale of drugs. The Sub-Committee...
    Will not sell sick pharma firms to foreign companies: Government

    Will not sell sick pharma firms to foreign companies: Government

    supriya kashyap kashyap5 Feb 2017 12:01 PM IST
    New Delhi : Amid Opposition protests, government said it will not sell sick pharma PSUs BCPL and HAL to foreign firms and closure of IDPL and RDPL...
    Jammu: Chemist on strike against Govt move

    Jammu: Chemist on strike against Govt move

    savita thakur thakur1 Feb 2017 3:08 PM IST
    Jammu: Chemists in this winter capital of the state went on strike against the move of Jammu and Kashmir Government of opening of medical shops inside...
    HC allows Indian firm to export drug in which Bayer has patent

    HC allows Indian firm to export drug in which Bayer has patent

    supriya kashyap kashyap30 Jan 2017 11:31 AM IST
    New Delhi : In a setback to German pharma major 'Bayer', Delhi High Court has suspended its order restraining an Indian drug company from...
    Donald Trumps policy not to hit Indian IT, pharma firms: Ananth Kumar

    Donald Trump's policy not to hit Indian IT, pharma firms: Ananth Kumar

    supriya kashyap kashyap30 Jan 2017 11:29 AM IST
    Bengaluru : Indian IT, Biotech and pharma industries will not be impacted due to Donald Trump's policies as the US is expected to continue "the...
    Guest Blog: Budget expectations with CEO Fortis Healthcare Ltd

    Guest Blog: Budget expectations with CEO Fortis Healthcare Ltd

    supriya kashyap kashyap29 Jan 2017 1:36 PM IST
    As the Nation looks forward to the Union Budget 2017, there is a lot of hope and anticipation especially for healthcare, which needs to be viewed as a...
    GST on healthcare will make medicare unaffordable, says ASSOCHAM-TechSci study

    GST on healthcare will make medicare unaffordable, says ASSOCHAM-TechSci study

    savita thakur thakur28 Jan 2017 12:27 PM IST
    New Delhi: The healthcare sector catering to the unmet health needs of the society should be kept out of the purview of the Goods and Services Tax...
    Healthcare sector should be accorded National Priority status: NATHEALTH

    Healthcare sector should be accorded National Priority status: NATHEALTH

    supriya kashyap kashyap26 Jan 2017 11:14 AM IST
    India continues to rank low on many of the basic health indicators. Apart from trailing developed nations, India compares un-favorably even with its...
    Trump may not enforce individual health insurance mandate: Aide

    Trump may not enforce individual health insurance mandate: Aide

    supriya kashyap kashyap23 Jan 2017 11:39 AM IST
    The Trump administration may no longer enforce a rule requiring individual Americans to carry health insurance or pay a penalty if they do not, a...
    PrevNext

    Popular Stories

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    IPA releases Best Practices for Employee Safety in Pharmaceutical Manufacturing during COVID-19

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung...

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok